XML 56 R43.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies - Additional Information (Detail)
€ in Millions
1 Months Ended 12 Months Ended
Jan. 01, 2022
USD ($)
Jun. 30, 2021
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2023
EUR (€)
Sep. 30, 2023
EUR (€)
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Jul. 01, 2013
USD ($)
Summary Of Significant Accounting Policies [Line Items]                    
Accretion or amortization     $ 1,600,000 $ 700,000            
Allowance for credit losses     $ 0 0            
Purchase of available-for-sale securities       5,000,000 $ 3,000,000          
Percentage of future royalties     1.00%              
Loss on purchase commitments | €           € 59.5 € 61.1      
MidCap Credit Facility                    
Summary Of Significant Accounting Policies [Line Items]                    
Principal amount     $ 33,300,000 40,000,000.0            
Milestone Rights Liability | Deerfield                    
Summary Of Significant Accounting Policies [Line Items]                    
Contingent liability remain payable     900,000 1,100,000           $ 55,000,000
Contingent liability for milestone payments               $ 5,000,000 $ 5,000,000  
Convertible Promissory Note | Thirona Bio, Inc.                    
Summary Of Significant Accounting Policies [Line Items]                    
Purchase of available-for-sale securities $ 5,000,000.0 $ 3,000,000.0                
Interest rate   6.00%                
Investment securities     6,900,000 7,100,000            
Available-for-Sale Investment, credit losses     200,000 900,000            
Principal amount     8,000,000              
Insulin                    
Summary Of Significant Accounting Policies [Line Items]                    
Loss on purchase commitments     $ 64,800,000 $ 72,300,000            
Tyvaso DPI                    
Summary Of Significant Accounting Policies [Line Items]                    
Percentage of royalty on net sales     10.00%              
Percentage of royalty on net revenue     10.00%              
Percentage of future royalties     9.00%              
Minimum | AFREZZA product sales                    
Summary Of Significant Accounting Policies [Line Items]                    
Sales return right following product expiration in months     6 months              
Maximum | Milestone Rights Liability | Deerfield                    
Summary Of Significant Accounting Policies [Line Items]                    
Contingent liability for milestone payments                   $ 90,000,000
Maximum | AFREZZA product sales                    
Summary Of Significant Accounting Policies [Line Items]                    
Sales return right following product expiration in months     12 months